Type: Press Release
… DANVERS Mass – April 26 2022 – Abiomed (Nasdaq ABMD) announces the first patient … failure For additional information please visit wwwabiomedcom ABOUT IMPELLA HEART PUMPS The Impella 25® and Impella … periodic reports on file with the Securities and Exchange Commission Actual results may differ materially from …
Type: Press Release
… (HRPCI) patients will be presented during the upcoming Cardiovascular Research Technologies (CRT) 2023 … Fraction The Protect III Study Date/Time Sunday Feb 26 230-240 pm ET Kent Theater Symposium – High Risk High … shock patients The FDA’s decision is based on multiple studies and publications and a recently published AHA …
Type: Landing
… of California Abiomed adopts this Supplemental Notice to comply with these provisions including CCPA Any terms … California Civil Code Section § 179883 permits users of the Websites that are California residents to request certain …
Type: Press Release
… multimedia View the full release here https//wwwbusinesswirecom/news/home/20210629005367/en/ Impella RP with SmartAssist … internet-connected device through a secure HIPAA-compliant website SmartAssist technology is also available on Impella …
Type: Press Release
… through a robust pipeline of technologies and clinical studies This combination broadens Johnson & Johnson’s position … at 800 am ET Participant Dial-In 877-869-3847 / +1 201-689-8261 … These documents will be available at no charge on the SEC’s website at wwwsecgov In addition a copy of the offer to …
Type: Press Release
… fourth quarter fiscal 2012 revenue of $373 million up 31% compared to revenue of $285 million in the same period of fiscal 2011 and GAAP net income of $26 million or $006 per diluted share compared to GAAP net … the prior year For the full fiscal year total revenue was $1264 million up 25% compared to revenue of $1012 million in …
Type: Press Release
… shock as demonstrated in multiple prospective studies” said William O’Neill MD medical director of the Center … achieve a global AMI cardiogenic shock Class I guideline recommendation for Impella and related best practice protocols … (n=18) IMPRESS in Cardiac Arrest (n=48) Seyfarth et al (n=26) and the Abiomed-sponsored FDA RECOVER II RCT (n=1) All …
Type: Press Release
… Danvers Mass October 26 2022 – Abiomed (Nasdaq ABMD) announces a new program to address healthcare disparities in underserved communities as new data provides an example of how better … Impella heart pump had significantly improved clinical outcomes compared to those who were treated with the …
Type: Press Release
… DANVERS Mass Oct 26 2017 (GLOBE NEWSWIRE) -- Abiomed Inc (NASDAQABMD) a … medical field" Japanese researchers and physicians have studied hemodynamic science and heart recovery for decades … Impella patient marks a significant milestone for our Company" said Michael R Minogue President Chairman and Chief …
Type: Press Release
… results of the PROTECT III and Restore EF prospective studies demonstrate improved outcomes for high-risk PCI patients with the use of Impella … contemporary data from these two prospective studies provide evidence that the adoption of Impella best …